Filing Details
- Accession Number:
- 0001103021-22-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-08 20:55:05
- Reporting Period:
- 2022-02-04
- Accepted Time:
- 2022-02-08 20:55:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1757833 | James Vollins | C/O Biodelivery Sciences Intl, Inc. 4131 Parklake Ave. Suite 225 Raleigh NC 27612 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-02-04 | 18,541 | $3.60 | 9,872 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-02-04 | 9,872 | $3.66 | 0 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | F | Direct |
Footnotes
- The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan.
- The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to vesting Restricted Stock Units.